High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.
about
Yellow fever vaccines and international travelersAdvanced Yellow Fever Virus Genome Detection in Point-of-Care Facilities and Reference LaboratoriesAdvanced vaccine candidates for Lassa feverImmune activation alters cellular and humoral responses to yellow fever 17D vaccineCurrent progress in dengue vaccinesDevelopment of RT-LAMP and real-time RT-PCR assays for the rapid detection of the new duck Tembusu-like BYD virus.Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in miceImmune response during adverse events after 17D-derived yellow fever vaccination in Europe.Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parametersLive virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessmentA randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of KoreaComparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing.IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.Review of the risks and benefits of yellow fever vaccination including some new analyses.Safety profile of the yellow fever vaccine Stamaril®: a 17-year review.Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.Development of Sanofi Pasteur tetravalent dengue vaccine.Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial.
P2860
Q22305943-4D653A71-F7DF-4D56-9742-76D3DB2DC6A6Q24289106-D799409C-4BC7-453C-8F35-12F481C9FC81Q26823627-C5B19E69-12A2-4D17-A8E4-819552C6AEB4Q28388716-3FF62EF4-AA36-4D94-99C0-79FD683EBA5CQ33408300-5FC28A99-9FB6-4526-BEAE-42C212E11CCAQ34292405-6B0537F9-EBE4-4086-9152-F8C36CD4D848Q34615061-C8E1FE42-3989-45E0-9E04-27347787F9EBQ34770828-3AEA0E41-3E69-4F52-8428-20D38C31237DQ35814851-05CE9561-A3BE-482F-B150-5C319C692A29Q35887307-A5B6EB31-6436-45DB-8093-2B8874D5A853Q36307457-E4BD7D40-0638-4E2C-9BE0-47B704B5CC87Q37159706-0C33DB95-0251-4D03-9517-14DCCB4C2F96Q37443100-DCF0DFD7-1F33-4B6A-B361-56FABDCFCBAAQ37812123-4B405078-898F-4D4C-AAF9-698A2D9B09DDQ38006992-720894A5-3E35-4012-89D5-F5EE1FF323B0Q38143159-9C9AF1CD-E5C2-4AD1-8DA6-3F840AD5235FQ38614539-64C4C779-665F-4719-A764-43851768539BQ40272663-D19BE474-8F64-43FF-99AC-3F8B2F34AA18Q47403621-210DB327-ED33-4E47-BCA7-DAC825881402
P2860
High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
High stability of yellow fever ...... sis of large-scale production.
@en
type
label
High stability of yellow fever ...... sis of large-scale production.
@en
prefLabel
High stability of yellow fever ...... sis of large-scale production.
@en
P2093
P1433
P1476
High stability of yellow fever ...... sis of large-scale production.
@en
P2093
P304
P356
10.1016/J.VACCINE.2006.06.082
P407
P577
2006-08-01T00:00:00Z